A novel gamma delta T cell platform technology to enable drug-tunable targeting of CAR tumour associated antigen targets

Project Details

Short titleA novel gamma delta T cell platform technology to enable drug-tunable targeting of CAR tumour associated antigen targets
StatusFinished
Effective start/end date3/04/172/10/19

Funding

  • THE WELLCOME TRUST